欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1193/004
药品名称
Padovel
活性成分
carbidopa 50.0 mg
entacapone 200.0 mg
levodopa 200.0 mg
剂型
Film-coated tablet
上市许可持有人
SVUS Pharma a.s.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Poland (PL)
Padovel
许可日期
2014/12/18
最近更新日期
2019/01/23
药物ATC编码
N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common_impack_blister_100_25_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_blister_150_37_5_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_blister_200_50_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_blister_50_12_5_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_bottle_100_25_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_bottle_150_37_5_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_bottle_200_50_200mg
Date of last change:2024/09/06
Final Product Information
|
common_impack_bottle_50_12_5_200mg
Date of last change:2024/09/06
Final Product Information
|
common_outer_blister_100_25_200mg
Date of last change:2024/09/06
Final Product Information
|
common_outer_blister_150_37_5_200mg
Date of last change:2024/09/06
Final Product Information
|
common_outer_blister_200_50_200mg
Date of last change:2024/09/06
Final Product Information
|
common_outer_blister_50_12_5_200mg
Date of last change:2024/09/06
Final Product Information
|
common_outer_bottle_100_25_200mg film_coated tablets
Date of last change:2024/09/06
Final Product Information
|
common_outer_bottle_150_37_5_200mg film_coated tablets
Date of last change:2024/09/06
Final Product Information
|
common_outer_bottle_200_50_200mg film_coated tablets
Date of last change:2024/09/06
Final Product Information
|
common_outer_bottle_50_12_5_200mg film_coated tablets
Date of last change:2024/09/06
Final Product Information
|
common_pil_100mg_25mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_pil_150mg_37_5mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_pil_200mg_37_5mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_pil_50mg_12_5mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_100mg_25mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_150mg_37_5mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_200mg_50mg_200mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_50mg_12_5mg_200mg
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase